Three trials were published comparing reboxetine against other antidepressants in which reboxetine was just as good, and they were published, but three times as many patients' worth of data was collected which showed that reboxetine was worse than those other treatments, and those trials were not published.
Tre forsøg blev offentliggjort,  som sammenlignede reboxetine med andre antidepressiver, hvor reboxetine var lige så godt, og de blev offentliggjort. Men tre data med gange så mange patienter blev indsamlet som viste at reboxetine var værre end disse andre behandlinger, og disse forsøg  blev ikke offentliggjort.